Biomedicine
"Female Viagra": maybe this time it will work?
The female analogue of Viagra, a drug called Tefina, is undergoing phase II clinical trials.
21.11.2012- English version
- Articles
- Life Sciences
- Biomedicine
Biomedicine
Found results: 2481
Biomedicine
Disable the "harmful" part of immunity
The method of selective suppression of the immune system can be used to treat multiple sclerosis and other autoimmune diseases, as well as to prevent complications after organ transplantation.
20.11.2012
Biomedicine
"Mini-cells" against cancer
The results of the clinical study showed that the introduction of "mini-cells" from the bacterial membrane is safe, well tolerated and even stabilizes the condition of patients with the last stages of incurable malignant tumors using traditional methods.
20.11.2012
Biomedicine
Cancer Immunotherapy: a mini-review
The reason for writing a review of advanced oncotherapy methods was the fact that the FDA included trastuzumab, a new drug for the treatment of an aggressive form of breast cancer, in its list of priorities.
15.11.2012
Biomedicine
A new method of catching cancer cells in the blood
The device developed at MTI pumps blood at a rate of 1 ml/h, 10 times faster than existing analogues, and catches 60-80% of cancer cells wandering in the blood. In the near future, the authors are going to increase the flow rate by 100 times.
13.11.2012
Biomedicine
Nose drops for diabetics
A new alternative to subcutaneous insulin injections can be a nasal spray, the composition of which turns into a gel at body temperature.
12.11.2012
Biomedicine
Three approaches to breast cancer treatment are tested in one clinic
At George Mason University, 3 clinical trials are being conducted simultaneously, within the framework of which different approaches to the treatment of breast cancer are being tested.
09.11.2012
Biomedicine
Another target of anti-cancer therapy
A drug that selectively suppresses the activity of the histone – 11 deathylase enzyme will be an effective antitumor drug without affecting normally functioning cells.
08.11.2012
Biomedicine
To assess the aggressiveness of diseases, an analysis of the activity of cathepsins will help
A blood test will predict the aggressiveness of atherosclerosis, osteoporosis and cancer by the activity of cathepsins – enzymes that destroy extracellular matrix proteins.
07.11.2012
Biomedicine
Blocking the enzyme will help with multiple sclerosis
Blocking the activity of the enzyme hyaluronidase stimulates the restoration of the myelin sheath of nerve fibers, which is destroyed in multiple sclerosis and other neurological diseases.
07.11.2012
Biomedicine
Different forms of cancer can be identified by a single biomarker
The method of early cancer diagnosis is based on the detection of the gammaH2AX protein produced in cells in response to DNA damage. It is believed that the appearance of this protein is one of the first steps on the cell's path to malignancy.
07.11.2012
Biomedicine
Alzheimer's disease can be detected long before it begins
In the brains of people genetically predisposed to the development of Alzheimer's disease, biomarkers of the disease can be detected more than 20 years before the first symptoms appear.
07.11.2012
Biomedicine
Will a mitochondrial antioxidant help with Huntington's disease?
Mice with the Huntington's disease model after the introduction of the synthetic mitochondrial antioxidant XJB-5-131 looked and behaved like healthy animals.
06.11.2012
Biomedicine
Anti-amphetamine vaccine tested on mice
The vaccine against amphetamine will deprive whole armies of ordinary hardworking drug dealers around the world of a piece of bread.
02.11.2012
Biomedicine
Multiple sclerosis can be treated with an anti-cancer drug
The third phase of clinical trials of the anti-cancer drug alemtuzumab confirmed its greater effectiveness compared to the standard interferon beta-1a used in the treatment of multiple sclerosis.
02.11.2012
Biomedicine
Vaccines from the printer are almost a reality
Craig Venter's group is testing an experimental version of a digital biological converter that allows "printing" vaccines.
31.10.2012
Biomedicine
Is resveratrol useless for healthy people?
In a study involving 29 post-menopausal women who did not have type 2 diabetes and were relatively healthy, it was not possible to detect the slightest effect from taking resveratrol.
26.10.2012
Biomedicine
Are you afraid of Alzheimer's disease? Do not be late with the start of HRT!
Starting hormone replacement therapy no later than 5 years after menopause reduces the risk of developing Alzheimer's disease by 30%. A later start of such therapy does not affect the likelihood of dementia.
26.10.2012
Biomedicine
A new epigenetic marker of breast cancer
The DOK7 gene as a marker of breast cancer has unique prognostic characteristics: hypermethylation of one of its promoters in peripheral blood cells can be detected several years before diagnosis.
23.10.2012
Biomedicine
Genetic Test Personalizes Heart Failure Therapy
The analysis of the variations of the two genes makes it possible to identify patients with congestive heart failure who respond positively to the beta-blocker bucindolol.
18.10.2012